Skip to main content
logo
Divi's Laboratories Limited (NSE:DIVISLAB)
India flag India · Delayed Price · Currency is INR
6,151.50
+123.50 (2.05%)
Aug 22, 2025, 3:30 PM IST

Divi's Laboratories Revenue

Divi's Laboratories had revenue of 24.10B INR in the quarter ending June 30, 2025, with 13.79% growth. This brings the company's revenue in the last twelve months to 96.52B, up 17.92% year-over-year. In the fiscal year ending March 31, 2025, Divi's Laboratories had annual revenue of 93.60B with 19.31% growth.

Revenue (ttm)
96.52B
Revenue Growth
+17.92%
P/S Ratio
16.92
Revenue / Employee
9.16M
Employees
10,542
Market Cap
1,633.03B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202593.60B15.15B19.31%
Mar 31, 202478.45B780.00M1.00%
Mar 31, 202377.67B-11.93B-13.31%
Mar 31, 202289.60B19.90B28.56%
Mar 31, 202169.69B15.75B29.20%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sun Pharmaceutical Industries537.77B
Cipla274.80B
Apollo Hospitals Enterprise225.51B
Mankind Pharma129.10B
Zydus Lifesciences236.08B
Fortis Healthcare80.94B
Alkem Laboratories133.04B
Aurobindo Pharma320.25B
Revenue Rankings

Divi's Laboratories News

More News